Status:

RECRUITING

Fosfomycin I.v. for Treatment of Severely Infected Patients

Lead Sponsor:

Infectopharm Arzneimittel GmbH

Collaborating Sponsors:

INPADS GmbH

Dr. Oestreich + Partner GmbH

Conditions:

Bacterial Infections

Bone Diseases, Infectious

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this European, multicentric, prospective, non-interventional study is to document and evaluate the efficacy and safety of the treatment of severely infected patients with intravenously ...

Eligibility Criteria

Inclusion

  • Male or female patients aged ≥ 18 years
  • Treatment with fosfomycin according to the (national) Summary of Product Characteristics (SmPC) of fosfomycin i.v.
  • Patients with osteomyelitis, complicated urinary tract infection, nosocomial lower respiratory tract infection, bacterial meningitis/central nervous system infection, bacteraemia/sepsis, skin and soft tissue infection, endocarditis or other infection, each as far as covered by the respective nationally relevant SmPC
  • Written informed consent of the participant (or person in charge in case of patients incapable of giving consent)

Exclusion

  • Previous documentation of the patient in the present study
  • Patients participating in an interventional clinical trial
  • Patients with known hypersensitivity to fosfomycin or any of the excipients
  • Terminally ill patients
  • Patients with "do not resuscitate order"
  • Palliative treatment approach
  • Failure of \> 3 of the following organ systems: respiratory system, nervous system, cardiovascular system, liver, coagulation, kidney
  • Manifest Human Immunodeficiency Virus (HIV) disease (Acquired Immunodeficiency Syndrome, AIDS)
  • Fosfomycin treatment as 4th line treatment or at later stage
  • Patients with involvement of fungi or mycobacteria in the targeted infection

Key Trial Info

Start Date :

December 1 2016

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2030

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT02979951

Start Date

December 1 2016

End Date

December 1 2030

Last Update

October 1 2024

Active Locations (50)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 13 (50 locations)

1

Landeskrankenhaus Hall - Tirol Kliniken

Hall in Tirol, Austria

2

A.ö. Bezirkskrankenhaus

Reutte, Austria

3

AKH Wien, Universitätsklinik für Innere Medizin 1

Vienna, Austria

4

Klinikum Wels-Grieskirchen, Institut für Hygiene und Mikrobiologie

Wels, Austria